Breedveld B, Schoonderwoerd K, Verhoeven A J, Willemsen R, Jansen H
Department of Biochemistry, Erasmus University Rotterdam, The Netherlands.
Biochem J. 1997 Jan 15;321 ( Pt 2)(Pt 2):425-30. doi: 10.1042/bj3210425.
Hepatic lipase (HL) is thought to be located at the vascular endothelium in the liver. However, it has also been implicated in the binding and internalization of chylomicron remnants in the parenchymal cells. In view of this apparent discrepancy between localization and function, we re-investigated the localization of HL in rat liver using biochemical and immunohistochemical techniques. The binding of HL to endothelial cells was studied in primary cultures of rat liver endothelial cells. Endothelial cells bound HL in a saturable manner with high affinity. However, the binding capacity accounted for at most 1% of the total HL activity present in the whole liver. These results contrasted with earlier studies, in which non-parenchymal cell (NPC) preparations had been found to bind HL with a high capacity. To study HL binding to the different components of the NPC preparations, we separated endothelial cells, Kupffer cells and blebs by counterflow elutriation. Kupffer cells and endothelial cells showed a relatively low HL-binding capacity. In contrast, the blebs, representing parenchymal-cell-derived material, had a high HL-binding capacity (33 m-units/mg of protein) and accounted for more than 80% of the total HL binding in the NPC preparation. In contrast with endothelial and Kupffer cells, the HL-binding capacity of parenchymal cells could account for almost all the HL activity found in the whole liver. These data strongly suggest that HL binding occurs at parenchymal liver cells. To confirm this conclusion in situ, we studied HL localization by immunocytochemical techniques. Using immunofluorescence, we confirmed the sinusoidal localization of HL. Immunoelectron microscopy demonstrated that virtually all HL was located at the microvilli of parenchymal liver cells, with a minor amount at the endothelium. We conclude that, in rat liver, HL is localized at the microvilli of parenchymal cells.
肝脂肪酶(HL)被认为位于肝脏的血管内皮。然而,它也与实质细胞中乳糜微粒残粒的结合及内化有关。鉴于这种定位与功能之间明显的差异,我们使用生化和免疫组化技术重新研究了HL在大鼠肝脏中的定位。在大鼠肝脏内皮细胞的原代培养中研究了HL与内皮细胞的结合。内皮细胞以高亲和力饱和方式结合HL。然而,结合能力最多占全肝中总HL活性的1%。这些结果与早期研究形成对比,早期研究发现非实质细胞(NPC)制剂能高容量结合HL。为研究HL与NPC制剂不同成分的结合,我们通过逆流淘析分离了内皮细胞、库普弗细胞和小泡。库普弗细胞和内皮细胞显示出相对较低的HL结合能力。相比之下,代表实质细胞衍生物质的小泡具有高HL结合能力(33 m单位/毫克蛋白质),占NPC制剂中总HL结合的80%以上。与内皮细胞和库普弗细胞不同,实质细胞的HL结合能力几乎可解释全肝中发现的所有HL活性。这些数据强烈表明HL结合发生在肝实质细胞。为在原位证实这一结论,我们通过免疫细胞化学技术研究了HL的定位。使用免疫荧光,我们证实了HL的窦状定位。免疫电子显微镜显示,几乎所有的HL都位于肝实质细胞的微绒毛处,少量位于内皮。我们得出结论,在大鼠肝脏中,HL定位于实质细胞的微绒毛。